{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:24:11Z","timestamp":1785803051579,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["COVID-19"],"award-info":[{"award-number":["COVID-19"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijid.2022.09.026","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T13:47:21Z","timestamp":1663768041000},"page":"143-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Improved survival in intensive care unit in severe COVID-19 associated with amantadine use - retrospective study"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-4152","authenticated-orcid":false,"given":"Daniel","family":"Chober","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenon","family":"Czajkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-3737","authenticated-orcid":false,"given":"Bogusz","family":"Aksak-W\u0105s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Dalewska-Kucharczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ho\u0142ubczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Karasi\u0144ska-Milchert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Jaremko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Skowron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malwina","family":"Karasi\u0144ska-Cie\u015blak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Parczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.09.026_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518824851","article-title":"The effect of oral administration of amantadine on neurological outcome of patients with diffuse axonal injury in ICU","volume":"13","author":"Abbasivash","year":"2019","journal-title":"J Exp Neurosci"},{"key":"10.1016\/j.ijid.2022.09.026_bib0002","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1016\/S2665-9913(20)30277-0","article-title":"Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study","volume":"2","author":"Biran","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2022.09.026_bib0003","article-title":"SARS-CoV-2 infection causes dopaminergic neuron senescence","author":"Chen","year":"2021","journal-title":"Research Square"},{"key":"10.1016\/j.ijid.2022.09.026_bib0004","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/jcm11092286","article-title":"Effectiveness of tocilizumab in patients with severe or critical lung involvement in COVID-19: a retrospective study","volume":"11","author":"Chober","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijid.2022.09.026_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108232","article-title":"Dopamine receptor activation increases HIV entry into primary human macrophages","volume":"9","author":"Gaskill","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2022.09.026_bib0006","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.1996.00550020101021","article-title":"The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis","volume":"53","author":"Geisler","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ijid.2022.09.026_bib0007","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/02699052.2018.1476733","article-title":"The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial","volume":"32","author":"Ghalaenovi","year":"2018","journal-title":"Brain Inj"},{"key":"10.1016\/j.ijid.2022.09.026_bib0008","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1102609","article-title":"Placebo-controlled trial of amantadine for severe traumatic brain injury","volume":"366","author":"Giacino","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.09.026_bib0009","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00002826-198908000-00003","article-title":"Amantadine: a new clinical profile for traumatic brain injury","volume":"12","author":"Gualtieri","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ijid.2022.09.026_bib0010","unstructured":"How long does it take for amantadine to start working? Drugs.com. https:\/\/www.drugs.com\/medical-answers\/long-amantadine-start-working-3546573\/, 2022 (accessed 22 May 2022)."},{"key":"10.1016\/j.ijid.2022.09.026_bib0011","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.0b013e31824e8f0d","article-title":"Amantadine: the journey from fighting flu to treating Parkinson disease","volume":"78","author":"Hubsher","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ijid.2022.09.026_bib0012","unstructured":"Influenza antiviral drug resistance, Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/flu\/treatment\/antiviralresistance.htm, 2021 (accessed 22 May 2022)."},{"key":"10.1016\/j.ijid.2022.09.026_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm10040217","article-title":"Anti-inflammatory effects of amantadine and memantine: possible therapeutics for the treatment of Covid-19?","volume":"10","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2020","journal-title":"J Pers Med"},{"key":"10.1016\/j.ijid.2022.09.026_bib0014","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/02699050400025059","article-title":"Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET)","volume":"19","author":"Kraus","year":"2005","journal-title":"Brain Inj"},{"key":"10.1016\/j.ijid.2022.09.026_bib0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S1734-1140(09)70173-2","article-title":"Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood","volume":"61","author":"Kubera","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.ijid.2022.09.026_bib0016","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12028-020-00986-4","article-title":"Amantadine and modafinil as neurostimulants following acute stroke: a retrospective study of intensive care unit patients","volume":"34","author":"Leclerc","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ijid.2022.09.026_bib0017","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12883-021-02444-w","article-title":"Early amantadine treatment reduces the risk of death in patients with large hemisphere infarctions:a Chinese hospital-based study","volume":"21","author":"Li","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ijid.2022.09.026_bib0019","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/clinids\/15.2.362","article-title":"Implications of viral resistance to amantadine in control of influenza","volume":"15","author":"Monto","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.09.026_bib0020","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/j.0953-816X.2004.03297.x","article-title":"Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine","volume":"19","author":"Peeters","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.ijid.2022.09.026_bib0021","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00702-004-0112-4","article-title":"The outcome of patients with severe head injuries treated with amantadine sulphate","volume":"111","author":"Saniova","year":"2004","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.ijid.2022.09.026_bib0022","first-page":"113","article-title":"Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury","volume":"13","author":"Shafiee","year":"2022","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.ijid.2022.09.026_bib0023","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fmicb.2017.00651","article-title":"Japanese encephalitis virus exploits dopamine D2 receptor-phospholipase C to target dopaminergic human neuronal cells","volume":"8","author":"Simanjuntak","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2022.09.026_bib0024","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/JTN.0000000000000138","article-title":"Amantadine to treat cognitive dysfunction in moderate to severe traumatic brain injury","volume":"22","author":"Stelmaschuk","year":"2015","journal-title":"J Trauma Nurs"},{"key":"10.1016\/j.ijid.2022.09.026_bib0025","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/0303-8467(92)90006-O","article-title":"Amantadine as N-methyl-D-aspartic acid receptor antagonist: new possibilities for therapeutic applications?","volume":"94","author":"Stoof","year":"1992","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ijid.2022.09.026_bib0026","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0165-5728(99)00093-4","article-title":"Effects of amantadine treatment on in vitro production of interleukin-2 in de-novo patients with idiopathic Parkinson's disease","volume":"98","author":"Wandinger","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ijid.2022.09.026_bib0027","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fnagi.2020.605330","article-title":"Amantadine alleviates postoperative cognitive dysfunction possibly by preserving neurotrophic factor expression and dendritic arborization in the hippocampus of old rodents","volume":"12","author":"Zhong","year":"2020","journal-title":"Front Aging Neurosci"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222005252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222005252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:53:49Z","timestamp":1778799229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222005252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":26,"alternative-id":["S1201971222005252"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.09.026","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved survival in intensive care unit in severe COVID-19 associated with amantadine use - retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}